Semin Respir Crit Care Med 2023; 44(06): 851-865
DOI: 10.1055/s-0043-1770123
Review Article

Perioperative Management in Pulmonary Endarterectomy

David P. Jenkins
1   Department of Cardiothoracic Surgery, Royal Papworth Hospital NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, United Kingdom
,
Guillermo Martinez
2   Department of Anaesthesiology, Royal Papworth Hospital NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, United Kingdom
,
Kiran Salaunkey
2   Department of Anaesthesiology, Royal Papworth Hospital NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, United Kingdom
,
S. Ashwin Reddy
3   Pulmonary Vascular Disease Unit, Royal Papworth Hospital NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, United Kingdom
,
Joanna Pepke-Zaba
3   Pulmonary Vascular Disease Unit, Royal Papworth Hospital NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, United Kingdom
› Author Affiliations

Abstract

Pulmonary endarterectomy (PEA) is the treatment of choice for patients with chronic thromboembolic pulmonary hypertension (PH), provided lesions are proximal enough in the pulmonary vasculature to be surgically accessible and the patient is well enough to benefit from the operation in the longer term. It is a major cardiothoracic operation, requiring specialized techniques and instruments developed over several decades to access and dissect out the intra-arterial fibrotic material. While in-hospital operative mortality is low (<5%), particularly in high-volume centers, careful perioperative management in the operating theater and intensive care is mandatory to balance ventricular performance, fluid balance, ventilation, and coagulation to avoid or treat complications. Reperfusion pulmonary edema, airway hemorrhage, and right ventricular failure are the most problematic complications, often requiring the use of extracorporeal membrane oxygenation to bridge to recovery. Successful PEA has been shown to improve both morbidity and mortality in large registries, with survival >70% at 10 years. For patients not suitable for PEA or with residual PH after PEA, balloon pulmonary angioplasty and/or PH medical therapy may prove beneficial. Here, we describe the indications for PEA, specific surgical and perioperative strategies, postoperative monitoring and management, and approaches for managing residual PH in the long term.



Publication History

Article published online:
24 July 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Humbert M, Kovacs G, Hoeper MM. et al; ESC/ERS Scientific Document Group. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2022; 43 (38) 3618-3731
  • 2 Delcroix M, Torbicki A, Gopalan D. et al. ERS statement on chronic thromboembolic pulmonary hypertension. Eur Respir J 2021; 57 (06) 2002828
  • 3 Riedel M, Stanek V, Widimsky J, Prerovsky I. Long term follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest 1982; 81 (02) 151-158
  • 4 Hurwitt ES, Schein CJ, Rifkin H, Lebendiger A. A surgical approach to the problem of chronic pulmonary artery obstruction due to thrombosis or stenosis. Ann Surg 1958; 147 (02) 157-165
  • 5 Allison PR, Dunnill MS, Marshall R. Pulmonary embolism. Thorax 1960; 15 (04) 273-283
  • 6 Snyder WA, Kent DC, Baisch BF. Successful endarterectomy of chronically occluded pulmonary artery. Clinical report and physiologic studies. J Thorac Cardiovasc Surg 1963; 45: 482-489
  • 7 Houk VN, Hufnagel CA, McClenathan JE, Moser KM. Chronic thrombotic obstruction of major pulmonary arteries. Report of a case successfully treated by thrombendarterectomy, and a review of the literature. Am J Med 1963; 35: 269-282
  • 8 White PD, Benjamin C. Case 32–1964—chest pain and dyspnea in thirty-nine-year-old man. N Engl J Med 1964; 271: 40-50
  • 9 Moser KM, Braunwald NS. Successful surgical intervention in severe chronic thromboembolic pulmonary hypertension. Chest 1973; 64 (01) 29-35
  • 10 Daily PO, Johnston GG, Simmons CJ, Moser KM. Surgical management of chronic pulmonary embolism: surgical treatment and late results. J Thorac Cardiovasc Surg 1980; 79 (04) 523-531
  • 11 Cabrol C, Cabrol A, Acar J. et al. Surgical correction of chronic postembolic obstructions of the pulmonary arteries. J Thorac Cardiovasc Surg 1978; 76 (05) 620-628
  • 12 Dor V, Jourdan J, Schmitt R, Sabatier M, Arnulf JJ, Kreitmann P. Delayed pulmonary thrombectomy via a peripheral approach in the treatment of pulmonary embolism and sequelae. Thorac Cardiovasc Surg 1981; 29 (04) 227-232
  • 13 Chitwood Jr WR, Sabiston Jr DC, Wechsler AS. Surgical treatment of chronic unresolved pulmonary embolism. Clin Chest Med 1984; 5 (03) 507-536
  • 14 Daily PO, Dembitsky WP, Peterson KL, Moser KM. Modifications of techniques and early results of pulmonary thromboendarterectomy for chronic pulmonary embolism. J Thorac Cardiovasc Surg 1987; 93 (02) 221-233
  • 15 Daily PO, Dembitsky WP, Daily RP. Dissectors for pulmonary thromboendarterectomy. Ann Thorac Surg 1991; 51 (05) 842-843
  • 16 Levinson RM, Shure D, Moser KM. Reperfusion pulmonary edema after pulmonary artery thromboendarterectomy. Am Rev Respir Dis 1986; 134 (06) 1241-1245
  • 17 Jamieson SW, Kapelanski DP, Sakakibara N. et al. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg 2003; 76 (05) 1457-1462 , discussion 1462–1464
  • 18 Madani MM. Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: state-of-the-art 2020. Pulm Circ 2021; 11 (02) 20 458940211007372
  • 19 Proceedings of the 3rd World Symposium on Pulmonary Arterial Hypertension. Venice, Italy, June 23–25, 2003. J Am Coll Cardiol 2004; Jun 43 (12 suppl): 1S-90S
  • 20 Madani MM. Surgical treatment of chronic thromboembolic pulmonary hypertension: pulmonary thromboendarterectomy. Methodist DeBakey Cardiovasc J 2016; 12 (04) 213-218
  • 21 Mayer E, Jenkins D, Lindner J. et al. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg 2011; 141 (03) 702-710
  • 22 Jenkins D, Madani M, Fadel E, D'Armini AM, Mayer E. Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension. Eur Respir Rev 2017; 26 (143) 160111
  • 23 Freed DH, Thomson BM, Berman M. et al. Survival after pulmonary thromboendarterectomy: effect of residual pulmonary hypertension. J Thorac Cardiovasc Surg 2011; 141 (02) 383-387
  • 24 D'Armini AM, Morsolini M, Mattiucci G. et al. Pulmonary endarterectomy for distal chronic thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg 2014; 148 (03) 1005-1011 , 1012.e1–1012.e2, discussion 1011–1012
  • 25 Delcroix M, Lang I, Pepke-Zaba J. et al. Long-term outcome of patients with chronic thromboembolic pulmonary hypertension: results from an International Prospective Registry. Circulation 2016; 133 (09) 859-871
  • 26 Lankeit M, Krieg V, Hobohm L. et al. Pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant 2017; S1053-2498 (17)31877-6
  • 27 Guth S, D'Armini AM, Delcroix M. et al. Current strategies for managing chronic thromboembolic pulmonary hypertension: results of the worldwide prospective CTEPH Registry. ERJ Open Res 2021; 7 (03) 00850-2020
  • 28 Cannon JE, Su L, Kiely DG. et al. Dynamic risk stratification of patient long-term outcome after pulmonary endarterectomy: results from the United Kingdom National Cohort. Circulation 2016; 133 (18) 1761-1771
  • 29 Newnham M, Bunclark K, Abraham N. et al. CAMPHOR score: patient-reported outcomes are improved by pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension. Eur Respir J 2020; 56 (04) 1902096
  • 30 Vuylsteke A, Sharples L, Charman G. et al. Circulatory arrest versus cerebral perfusion during pulmonary endarterectomy surgery (PEACOG): a randomised controlled trial. Lancet 2011; 378 (9800): 1379-1387
  • 31 Hsieh WC, Jansa P, Huang WC, Nižnanský M, Omara M, Lindner J. Residual pulmonary hypertension after pulmonary endarterectomy: a meta-analysis. J Thorac Cardiovasc Surg 2018; 156 (03) 1275-1287
  • 32 Kim NH, Delcroix M, Jais X. et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J 2019; 53 (01) 1801915
  • 33 Madani MM, Auger WR, Pretorius V. et al. Pulmonary endarterectomy: recent changes in a single institution's experience of more than 2,700 patients. Ann Thorac Surg 2012; 94 (01) 97-103 , discussion 103
  • 34 Madani M, Ogo T, Simonneau G. The changing landscape of chronic thromboembolic pulmonary hypertension management. Eur Respir Rev 2017; 26 (146) 170105
  • 35 Pepke-Zaba J, Delcroix M, Lang I. et al. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation 2011; 124 (18) 1973-1981
  • 36 Quadery SR, Swift AJ, Billings CG. et al. The impact of patient choice on survival in chronic thromboembolic pulmonary hypertension. Eur Respir J 2018; 52 (03) 1800589
  • 37 Kerr KM, Sternbach J, Fedullo P. et al. The impact of obesity on outcomes following pulmonary endarterectomy (PEA). Am J Respir Crit Care Med 187 ;2013: A3316
  • 38 Wiedenroth CB, Liebetrau C, Breithecker A. et al. Combined pulmonary endarterectomy and balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant 2016; 35 (05) 591-596
  • 39 Hoeper MM, Kramer T, Pan Z. et al. Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model. Eur Respir J 2017; 50 (02) 1700740
  • 40 Brookes JDL, Li C, Chung STW. et al. Pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension: a systematic review. Ann Cardiothorac Surg 2022; 11 (02) 68-81
  • 41 Humbert M, Farber HW, Ghofrani HA. et al. Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Eur Respir J 2019; 53 (06) 1802004
  • 42 Vonk Noordegraaf A, Chin KM, Haddad F. et al. Pathophysiology of the right ventricle and of the pulmonary circulation in pulmonary hypertension: an update. Eur Respir J 2019; 53 (01) 1801900
  • 43 Galiè N, Hoeper MM, Humbert M. et al; Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC); European Respiratory Society (ERS); International Society of Heart and Lung Transplantation (ISHLT).. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009; 34 (06) 1219-1263
  • 44 Monaco F, Di Prima AL, De Luca M, Barucco G, Zangrillo A. Periprocedural and perioperatory management of patients with tricuspid valve disease. Minerva Cardioangiol 2018; 66 (06) 691-699
  • 45 Harjola VP, Mebazaa A, Čelutkienė J. et al. Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology. Eur J Heart Fail 2016; 18 (03) 226-241
  • 46 Pepke-Zaba J, Ghofrani HA, Hoeper MM. Medical management of chronic thromboembolic pulmonary hypertension. Eur Respir Rev 2017; 26 (143) 160107
  • 47 Ghofrani HA, Simonneau G, D'Armini AM. et al; MERIT Study Investigators. Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study. Lancet Respir Med 2017; 5 (10) 785-794
  • 48 Ghofrani HA, D'Armini AM, Grimminger F. et al; CHEST-1 Study Group. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med 2013; 369 (04) 319-329
  • 49 Chen X, Zhai Z, Huang K, Xie W, Wan J, Wang C. Bosentan therapy for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a systemic review and meta-analysis. Clin Respir J 2018; 12 (06) 2065-2074
  • 50 Surie S, Reesink HJ, Marcus JT. et al. Bosentan treatment is associated with improvement of right ventricular function and remodeling in chronic thromboembolic pulmonary hypertension. Clin Cardiol 2013; 36 (11) 698-703
  • 51 van Thor MCJ, Ten Klooster L, Snijder RJ, Kelder JC, Mager JJ, Post MC. Bosentan or macitentan therapy in chronic thromboembolic pulmonary hypertension?. Lung 2019; 197 (06) 753-760
  • 52 Simonneau G, D'Armini AM, Ghofrani HA. et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2). Eur Respir J 2015; 45 (05) 1293-1302
  • 53 Zhu YJ, Zhou YP, Wei YP. et al. Association between anticoagulation outcomes and venous thromboembolism history in chronic thromboembolic pulmonary hypertension. Front Cardiovasc Med 2021; 8: 628284
  • 54 Bunclark K, Newnham M, Chiu YD. et al. A multicenter study of anticoagulation in operable chronic thromboembolic pulmonary hypertension. J Thromb Haemost 2020; 18 (01) 114-122
  • 55 Jujo-Sanada T, Tanabe N, Sakao S. et al. The anticoagulant effects of warfarin and the bleeding risk associated with its use in patients with chronic thromboembolic pulmonary hypertension at a specialist center in Japan: a retrospective cohort study. Pulm Circ 2017; 7 (03) 684-691
  • 56 Ortmann E, Besser MW, Sharples LD. et al. An exploratory cohort study comparing prothrombin complex concentrate and fresh frozen plasma for the treatment of coagulopathy after complex cardiac surgery. Anesth Analg 2015; 121 (01) 26-33
  • 57 Selleng S, Selleng K. Heparin-induced thrombocytopenia in cardiac surgery and critically ill patients. Thromb Haemost 2016; 116 (05) 843-851
  • 58 Pishko AM, Cuker A. Heparin-induced thrombocytopenia and cardiovascular surgery. Hematology (Am Soc Hematol Educ Program) 2021; 2021 (01) 536-544
  • 59 Singh P, Lai HM, Lerner RG, Chugh T, Aronow WS. Guidelines and the use of inferior vena cava filters: a review of an institutional experience. J Thromb Haemost 2009; 7 (01) 65-71
  • 60 Bikdeli B, Chatterjee S, Desai NR. et al. Inferior vena cava filters to prevent pulmonary embolism: systematic review and meta-analysis. J Am Coll Cardiol 2017; 70 (13) 1587-1597
  • 61 Vinke P, Koudstaal T, Muskens F. et al. Prevalence of micronutrient deficiencies and relationship with clinical and patient-related outcomes in pulmonary hypertension types I and IV. Nutrients 2021; 13 (11) 3923
  • 62 Blanche C, Alonso-Gonzalez R, Uribarri A. et al. Use of intravenous iron in cyanotic patients with congenital heart disease and/or pulmonary hypertension. Int J Cardiol 2018; 267: 79-83
  • 63 Mahesh B, Besser M, Ravaglioli A. et al. Pulmonary endarterectomy is effective and safe in patients with haemoglobinopathies and abnormal red blood cells: the Papworth experience. Eur J Cardiothorac Surg 2016; 50 (03) 537-541
  • 64 Shore-Lesserson L, Baker RA, Ferraris VA. et al. The Society of Thoracic Surgeons, the Society of Cardiovascular Anesthesiologists, and the American Society of ExtraCorporeal Technology: clinical practice guidelines-anticoagulation during Cardiopulmonary Bypass. Anesth Analg 2018; 126 (02) 413-424
  • 65 Pilkington SA, Taboada D, Martinez G. Pulmonary hypertension and its management in patients undergoing non-cardiac surgery. Anaesthesia 2015; 70 (01) 56-70
  • 66 Naeije R, Badagliacca R. The overloaded right heart and ventricular interdependence. Cardiovasc Res 2017; 113 (12) 1474-1485
  • 67 Price LC, Martinez G, Brame A. et al. Perioperative management of patients with pulmonary hypertension undergoing non-cardiothoracic, non-obstetric surgery: a systematic review and expert consensus statement. Br J Anaesth 2021; 126 (04) 774-790
  • 68 Crystal GJ, Pagel PS. Right ventricular perfusion: physiology and clinical implications. Anesthesiology 2018; 128 (01) 202-218
  • 69 Price LC, Forrest P, Sodhi V. et al. Use of vasopressin after caesarean section in idiopathic pulmonary arterial hypertension. Br J Anaesth 2007; 99 (04) 552-555
  • 70 Sugawara Y, Mizuno Y, Oku S, Goto T. Effects of vasopressin during a pulmonary hypertensive crisis induced by acute hypoxia in a rat model of pulmonary hypertension. Br J Anaesth 2019; 122 (04) 437-447
  • 71 Hoeper MM, Maier R, Tongers J. et al. Determination of cardiac output by the Fick method, thermodilution, and acetylene rebreathing in pulmonary hypertension. Am J Respir Crit Care Med 1999; 160 (02) 535-541
  • 72 Nicoara A, Skubas N, Ad N. et al. Guidelines for the use of transesophageal echocardiography to assist with surgical decision-making in the operating room: a surgery-based approach: from the American Society of Echocardiography in Collaboration with the Society of Cardiovascular Anesthesiologists and the Society of Thoracic Surgeons. J Am Soc Echocardiogr 2020; 33 (06) 692-734
  • 73 Vandenheuvel M, Bouchez S, Wouters P, Mauermann E. Assessing right ventricular function in the perioperative setting, Part II: What about catheters?. Anesthesiol Clin 2019; 37 (04) 697-712
  • 74 Vandenheuvel M, Bouchez S, Wouters P, Mauermann E. Assessing right ventricular function in the perioperative setting, Part I: Echo-based measurements. Anesthesiol Clin 2019; 37 (04) 675-695
  • 75 Minatsuki S, Hatano M, Maki H, Takimoto E, Morita H, Komuro I. Analysis of oxygenation in chronic thromboembolic pulmonary hypertension using dead space ratio and intrapulmonary shunt ratio. Int Heart J 2019; 60 (05) 1137-1141
  • 76 Bancal C, Arnoult F, Krapf L, Bonay M. Patent foramen ovale and hypoxaemia with or without elevated right heart pressures [in French]. Rev Mal Respir 2011; 28 (08) 967-977
  • 77 Zhen Y, Zhang J, Liu X. et al. Impact of pulmonary thromboendarterectomy on tricuspid regurgitation in patients with chronic thromboembolic pulmonary hypertension: a single-center prospective cohort experience. J Thorac Dis 2020; 12 (03) 758-764
  • 78 Pearce B, Hu R, Desmond F, Banyasz D, Jones R, Tan CO. Intraoperative TOE guided management of newly diagnosed severe tricuspid regurgitation and pulmonary hypertension during orthotopic liver transplantation: a case report demonstrating the importance of reversibility as a favorable prognostic factor. BMC Anesthesiol 2019; 19 (01) 128
  • 79 Rudski LG, Lai WW, Afilalo J. et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010; 23 (07) 685-713 , quiz 786–788
  • 80 Nayak R, Fernandes TM, Auger WR, Pretorius GV, Madani MM, Birgersdotter-Green UM. Contribution of cardiac implantable electronic devices to thrombus formation in patients with chronic thromboembolic pulmonary hypertension. JACC Clin Electrophysiol 2018; 4 (11) 1431-1436
  • 81 Tempe DK, Batra UB, Datt V, Tomar AS, Virmani S. Where does the pulmonary artery catheter float: transesophageal echocardiography evaluation. Ann Card Anaesth 2015; 18 (04) 491-494
  • 82 Orihashi K, Nakashima Y, Sueda T, Yamanoue T, Yuge O, Matsuura Y. Usefulness of transesophageal echocardiography for guiding pulmonary artery catheter placement in the operating room. Heart Vessels 1994; 9 (06) 315-321
  • 83 Miles LF, Joshi KR, Ogilvie EH. et al. General anaesthesia vs. conscious sedation for transfemoral aortic valve implantation: a single UK centre before-and-after study. Anaesthesia 2016; 71 (08) 892-900
  • 84 Kunst G, Milojevic M, Boer C. et al; Authors/Task Force Members; EACTS/EACTA/EBCP Committee Reviewers.. 2019 EACTS/EACTA/EBCP guidelines on cardiopulmonary bypass in adult cardiac surgery. Br J Anaesth 2019; 123 (06) 713-757
  • 85 Veerhoek D, van Barneveld LJ, Haumann RG. et al. Anticoagulation management during pulmonary endarterectomy with cardiopulmonary bypass and deep hypothermic circulatory arrest. Perfusion 2021; 36 (01) 87-96
  • 86 Myles PS, Smith JA, Forbes A. et al; ATACAS Investigators of the ANZCA Clinical Trials Network. Tranexamic acid in patients undergoing coronary-artery surgery. N Engl J Med 2017; 376 (02) 136-148
  • 87 Jerath A, Yang QJ, Pang KS. et al. Tranexamic acid dosing for cardiac surgical patients with chronic renal dysfunction: a new dosing regimen. Anesth Analg 2018; 127 (06) 1323-1332
  • 88 Hulde N, Zittermann A, Deutsch MA, von Dossow V, Gummert JF, Koster A. Tranexamic acid and convulsive seizures after off-pump coronary artery bypass surgery: the role of renal insufficiency. Interact Cardiovasc Thorac Surg 2019; 29 (06) 852-854
  • 89 Rosenkranz S, Howard LS, Gomberg-Maitland M, Hoeper MM. Systemic consequences of pulmonary hypertension and right-sided heart failure. Circulation 2020; 141 (08) 678-693
  • 90 Crystal GJ, Kim SJ, Salem MR. Right and left ventricular O2 uptake during hemodilution and beta-adrenergic stimulation. Am J Physiol 1993; 265 (5, Pt 2): H1769-H1777
  • 91 Barile L, Fominskiy E, Di Tomasso N. et al. Acute normovolemic hemodilution reduces allogeneic red blood cell transfusion in cardiac surgery: a systematic review and meta-analysis of randomized trials. Anesth Analg 2017; 124 (03) 743-752
  • 92 Mladinov D, Eudailey KW, Padilla LA. et al. Effects of acute normovolemic hemodilution on post-cardiopulmonary bypass coagulation tests and allogeneic blood transfusion in thoracic aortic repair surgery: an observational cohort study. J Card Surg 2021; 36 (11) 4075-4082
  • 93 Cinà CS, Clase CM, Bruin G. Effects of acute normovolaemic haemodilution and partial exchange transfusion on blood product utilization, haemostasis and haemodynamics in surgery of the thoracoabdominal aorta. A cohort study in consecutive patients. Panminerva Med 2000; 42 (03) 211-215
  • 94 Madani MM, Jamieson SW. Technical advances of pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Semin Thorac Cardiovasc Surg 2006; 18 (03) 243-249
  • 95 Chau KH, Friedman T, Tranquilli M, Elefteriades JA. Deep hypothermic circulatory arrest effectively preserves neurocognitive function. Ann Thorac Surg 2013; 96 (05) 1553-1559
  • 96 Abdul Aziz KA, Meduoye A. Is pH-stat or alpha-stat the best technique to follow in patients undergoing deep hypothermic circulatory arrest?. Interact Cardiovasc Thorac Surg 2010; 10 (02) 271-282
  • 97 Kim WG, Lim C, Moon HJ, Kim YJ. Comparative analysis of alpha-stat and pH-stat strategies with a membrane oxygenator during deep hypothermic circulatory arrest in young pigs. Artif Organs 2000; 24 (11) 908-912
  • 98 Markowitz SD, Mendoza-Paredes A, Liu H. et al. Response of brain oxygenation and metabolism to deep hypothermic circulatory arrest in newborn piglets: comparison of pH-stat and alpha-stat strategies. Ann Thorac Surg 2007; 84 (01) 170-176
  • 99 Broderick P, Damberg A, Ziganshin BA, Elefteriades JA. Alpha-stat versus pH-stat: we do not pay it much mind. J Thorac Cardiovasc Surg 2018; 156 (01) 41-42
  • 100 O'Neill B, Bilal H, Mahmood S, Waterworth P. Is it worth packing the head with ice in patients undergoing deep hypothermic circulatory arrest?. Interact Cardiovasc Thorac Surg 2012; 15 (04) 696-701
  • 101 Kerr KM, Auger WR, Marsh JJ. et al. Efficacy of methylprednisolone in preventing lung injury following pulmonary thromboendarterectomy. Chest 2012; 141 (01) 27-35
  • 102 Gordan ML, Kellermann K, Blobner M, Nollert G, Kochs EF, Jungwirth B. Fast rewarming after deep hypothermic circulatory arrest in rats impairs histologic outcome and increases NFκB expression in the brain. Perfusion 2010; 25 (05) 349-354
  • 103 Di Mauro M, Iacò AL, Di Lorenzo C. et al. Cold reperfusion before rewarming reduces neurological events after deep hypothermic circulatory arrest. Eur J Cardiothorac Surg 2013; 43 (01) 168-173
  • 104 Grigore AM, Grocott HP, Mathew JP. et al; Neurologic Outcome Research Group of the Duke Heart Center. The rewarming rate and increased peak temperature alter neurocognitive outcome after cardiac surgery. Anesth Analg 2002; 94 (01) 4-10
  • 105 Stanzel RDP, Gehron J, Wolff M. et al. International survey on the perioperative management of pulmonary endarterectomy: the perfusion perspective. Perfusion 2018; 33 (01) 53-61
  • 106 Jujo T, Tanabe N, Sakao S. et al. Severe pulmonary arteriopathy is associated with persistent hypoxemia after pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension. PLoS One 2016; 11 (08) e0161827
  • 107 Manecke Jr GR, Kotzur A, Atkins G. et al. Massive pulmonary hemorrhage after pulmonary thromboendarterectomy. Anesth Analg 2004; 99 (03) 672-675
  • 108 Morsolini M, Azzaretti A, Orlandoni G, D'Armini AM. Airway bleeding during pulmonary endarterectomy: the “bubbles” technique. J Thorac Cardiovasc Surg 2013; 145 (05) 1409-1410
  • 109 Dalia AA, Streckenbach S, Andrawes M, Channick R, Wright C, Fitzsimons M. Management of pulmonary hemorrhage complicating pulmonary thromboendarterectomy. Front Med (Lausanne) 2018; 5: 326
  • 110 Berman M, Tsui S, Vuylsteke A. et al. Successful extracorporeal membrane oxygenation support after pulmonary thromboendarterectomy. Ann Thorac Surg 2008; 86 (04) 1261-1267
  • 111 Nierlich P, Ristl R. Perioperative extracorporeal membrane oxygenation bridging in patients undergoing pulmonary endarterectomy. Interact Cardiovasc Thorac Surg 2016; 22 (02) 181-187
  • 112 Kelava M, Koprivanac M, Smedira N, Mihaljevic T, Alfirevic A. Extracorporeal membrane oxygenation in pulmonary endarterectomy patients. J Cardiothorac Vasc Anesth 2019; 33 (01) 60-69
  • 113 Ogino H, Ando M, Matsuda H. et al. Japanese single-center experience of surgery for chronic thromboembolic pulmonary hypertension. Ann Thorac Surg 2006; 82 (02) 630-636
  • 114 Stéphan F, Mazeraud A, Laverdure F, Camous J, Fadel E. Evaluation of reperfusion pulmonary edema by extravascular lung water measurements after pulmonary endarterectomy. Crit Care Med 2017; 45 (04) e409-e417
  • 115 Miller Jr. WT, Osiason AW, Langlotz CP, Palevsky HI. Reperfusion edema after thromboendarterectomy: radiographic patterns of disease. J Thorac Imaging 1998; 13 (03) 178-183
  • 116 Kerr KM, Auger WR, Marsh JJ. et al. The use of cylexin (CY-1503) in prevention of reperfusion lung injury in patients undergoing pulmonary thromboendarterectomy. Am J Respir Crit Care Med 2000; 162 (01) 14-20
  • 117 Bates DM, Fernandes TM, Duwe BV. et al. Efficacy of a low-tidal volume ventilation strategy to prevent reperfusion lung injury after pulmonary thromboendarterectomy. Ann Am Thorac Soc 2015; 12 (10) 1520-1527
  • 118 Boulate D, Mercier O, Mussot S. et al. Extracorporeal life support after pulmonary endarterectomy as a bridge to recovery or transplantation: lessons from 31 consecutive patients. Ann Thorac Surg 2016; 102 (01) 260-268
  • 119 Kramm T, Eberle B, Guth S, Mayer E. Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy. Eur J Cardiothorac Surg 2005; 28 (06) 882-888
  • 120 Abe S, Ishida K, Masuda M. et al. A prospective, randomized study of inhaled prostacyclin versus nitric oxide in patients with residual pulmonary hypertension after pulmonary endarterectomy. Gen Thorac Cardiovasc Surg 2017; 65 (03) 153-159
  • 121 Imanaka H, Miyano H, Takeuchi M, Kumon K, Ando M. Effects of nitric oxide inhalation after pulmonary thromboendarterectomy for chronic pulmonary thromboembolism. Chest 2000; 118 (01) 39-46
  • 122 Flondor M, Merkel M, Hofstetter C, Irlbeck M, Frey L, Zwissler B. The effect of inhaled nitric oxide and inhaled iloprost on hypoxaemia in a patient with pulmonary hypertension after pulmonary thrombarterectomy. Anaesthesia 2006; 61 (12) 1200-1203
  • 123 Mo M, Kapelanski DP, Mitruka SN. et al. Reoperative pulmonary thromboendarterectomy. Ann Thorac Surg 1999; 68 (05) 1770-1776 , discussion 1776–1777
  • 124 Collaud S, Brenot P, Mercier O, Fadel E. Rescue balloon pulmonary angioplasty for early failure of pulmonary endarterectomy: the earlier the better?. Int J Cardiol 2016; 222: 39-40
  • 125 Stephens RS, Whitman GJ. Postoperative critical care of the adult cardiac surgical patient. Part I: Routine postoperative care. Crit Care Med 2015; 43 (07) 1477-1497
  • 126 Kogan A, Preisman S, Levin S, Raanani E, Sternik L. Adult respiratory distress syndrome following cardiac surgery. J Card Surg 2014; 29 (01) 41-46
  • 127 Catchpole KR, de Leval MR, McEwan A. et al. Patient handover from surgery to intensive care: using Formula 1 pit-stop and aviation models to improve safety and quality. Paediatr Anaesth 2007; 17 (05) 470-478
  • 128 Guinot PG, Spitz A, Berthoud V. et al. Effect of opioid-free anaesthesia on post-operative period in cardiac surgery: a retrospective matched case-control study. BMC Anesthesiol 2019; 19 (01) 136
  • 129 Giménez-Milà M, Videla S, Jenkins D. et al. Acute pain and analgesic requirements after pulmonary endarterectomy with deep hypothermic circulatory arrest. J Cardiothorac Vasc Anesth 2016; 30 (04) 993-996
  • 130 Mathis MR, Duggal NM, Likosky DS. et al. Intraoperative mechanical ventilation and postoperative pulmonary complications after cardiac surgery. Anesthesiology 2019; 131 (05) 1046-1062
  • 131 Chauhan S, Saxena N, Mehrotra S, Rao BH, Sahu M. Femoral artery pressures are more reliable than radial artery pressures on initiation of cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2000; 14 (03) 274-276
  • 132 Butchart AG, Zochios V, Villar SS. et al. Measurement of extravascular lung water to diagnose severe reperfusion lung injury following pulmonary endarterectomy: a prospective cohort clinical validation study. Anaesthesia 2019; 74 (10) 1282-1289
  • 133 Toraman F, Evrenkaya S, Yuce M. et al. Highly positive intraoperative fluid balance during cardiac surgery is associated with adverse outcome. Perfusion 2004; 19 (02) 85-91
  • 134 Shen W, Aguilar R, Montero AR. et al. Acute kidney injury and in-hospital mortality after coronary artery bypass graft versus percutaneous coronary intervention: a nationwide study. Am J Nephrol 2017; 45 (03) 217-225
  • 135 Mailhot T, Cossette S, Lambert J. et al. Delirium after cardiac surgery and cumulative fluid balance: a case-control cohort study. J Cardiothorac Vasc Anesth 2019; 33 (01) 93-101
  • 136 Karkouti K, Wijeysundera DN, Yau TM. et al. Acute kidney injury after cardiac surgery: focus on modifiable risk factors. Circulation 2009; 119 (04) 495-502
  • 137 Li C, Wang H, Liu N. et al; Beijing Acute Kidney Injury Trial (BAKIT) Workgroup. Early negative fluid balance is associated with lower mortality after cardiovascular surgery. Perfusion 2018; 33 (08) 630-637
  • 138 Wang AS, Nemeth S, Kurlansky P, Brady D, Rosenzweig EB, Takeda K. Severe postoperative acute kidney injury linked to worse two-year survival in pulmonary thromboendarterectomy patients. J Heart Lung Transplant 2022; 41: 141-144
  • 139 Serraino GF, Murphy GJ. Routine use of viscoelastic blood tests for diagnosis and treatment of coagulopathic bleeding in cardiac surgery: updated systematic review and meta-analysis. Br J Anaesth 2017; 118 (06) 823-833
  • 140 Jeong I, Alotaibi M, Fernandes TM. et al. Direct oral anticoagulants in patients with chronic thromboembolic pulmonary hypertension and the presence of recent thrombus during pulmonary endarterectomy. Pulm Circ 2022; 12 (03) e12110
  • 141 Olman MA, Auger WR, Fedullo PF, Moser KM. Pulmonary vascular steal in chronic thromboembolic pulmonary hypertension. Chest 1990; 98 (06) 1430-1434
  • 142 Yap J, Ruan W, Chia A. et al. Is subdural hemorrhage after pulmonary endarterectomy underrecognized?. J Thorac Cardiovasc Surg 2018; 156 (05) 2039-2042
  • 143 Condliffe R, Kiely DG, Gibbs JS. et al. Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 2008; 177 (10) 1122-1127
  • 144 Ali JM, Dunning J, Ng C. et al. The outcome of reoperative pulmonary endarterectomy surgery. Interact Cardiovasc Thorac Surg 2018; 26 (06) 932-937
  • 145 Guth S, Wiedenroth CB, Rieth A. et al. Exercise right heart catheterisation before and after pulmonary endarterectomy in patients with chronic thromboembolic disease. Eur Respir J 2018; 52 (03) 1800458
  • 146 Taboada D, Pepke-Zaba J, Jenkins DP. et al. Outcome of pulmonary endarterectomy in symptomatic chronic thromboembolic disease. Eur Respir J 2014; 44 (06) 1635-1645
  • 147 Galiè N, McLaughlin VV, Rubin LJ, Simonneau G. An overview of the 6th World Symposium on Pulmonary Hypertension. Eur Respir J 2019; 53 (01) 1802148